The Effects of Curcumin on Inflammasome: Latest Update

Molecules. 2023 Jan 11;28(2):742. doi: 10.3390/molecules28020742.

Abstract

Curcumin, a traditional Chinese medicine extracted from natural plant rhizomes, has become a candidate drug for the treatment of different diseases due to its anti-inflammatory, anticancer, antioxidant, and antibacterial activities. Curcumin is generally beneficial to improve human health with anti-inflammatory and antioxidative properties as well as antitumor and immunoregulatory properties. Inflammasomes are NLR family, pyrin domain-containing 3 (NLRP3) proteins that are activated in response to a variety of stress signals and that promote the proteolytic conversion of pro-interleukin-1β and pro-interleukin-18 into active forms, which are central mediators of the inflammatory response; inflammasomes can also induce pyroptosis, a type of cell death. The NLRP3 protein is involved in a variety of inflammatory pathologies, including neurological and autoimmune disorders, lung diseases, atherosclerosis, myocardial infarction, and many others. Different functional foods may have preventive and therapeutic effects in a wide range of pathologies in which inflammasome proteins are activated. In this review, we have focused on curcumin and evidenced its therapeutic potential in inflammatory diseases such as neurodegenerative diseases, respiratory diseases, and arthritis by acting on the inflammasome.

Keywords: anti-inflammatory; arthritic diseases; curcumin; diseases; inflammasome; lung diseases; natural flavonoid; neuroinflammation.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants
  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Humans
  • Inflammasomes* / metabolism
  • Interleukin-1beta / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism

Substances

  • Inflammasomes
  • Curcumin
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Anti-Inflammatory Agents
  • Antioxidants
  • Interleukin-1beta

Grants and funding

This research received no external funding.